Remote Ischemic Preconditioning Improves Cerebrovascular Function

Serial dCA measurements were performed at seven time points over 25 hours, with or without RIPC. Blood biomarkers, including five neuroprotective factors and 25 inflammation-related biomarkers, were measured with a quantitative protein chip.

The results showed that dCA significantly increased six hours after RIPC compared with the results on the day without RIPC, and the increase was sustained for at least 24 hours. Compared with baseline levels, there were significant increases in two neuroprotective factors (glial cell-derived neurotrophic factor and vascular endothelial growth factor-A) and four biomarkers (transforming growth factor-β1, leukemia inhibitory factor, matrix metallopeptidase-9, and tissue inhibitor of metalloproteinase-1). In addition, monocyte chemoattractant protein-1 was significantly lower than its baseline level. The study was published on May 29, 2019, in Neurology.

“The increased dCA and altered blood biomarkers may contribute at least partially to the beneficial effects of RIPC on cerebrovascular function,” concluded lead author Zhen-Ni Guo, MD, of First Hospital of Jilin University, and colleagues. “RIPC was also associated with changes in some neuroprotective and inflammation-related biomarkers in blood.”

RIPC involves repetitive cycles of transient ischemia of non-vital tissue to help remote vital organs withstand a subsequent prolonged ischemic event and the eventual reperfusion. It usually consists of three or four five minute cycles of right upper arm ischemia, induced by an automated cuff inflated to 200 mmHg, with an intervening five minutes of reperfusion during which the cuff is deflated.

Related Links:
Jilin University
Sun Yat-Sen University